Don’t miss outtag icon
Are you tracking AI visibility, or guessing? Get clarity with Similarweb’s AEO ToolkitTry it nowbanner icon

NeuroSphere Digital Health App analisi dell'app per 14 gennaio

NeuroSphere Digital Health App

NeuroSphere Digital Health App

  • Abbott
  • App Store di Apple
  • Gratis
  • Settore Medico
The NeuroSphere™ Digital Health App from Abbott is for people living with chronic pain and movement disorders, allowing them to manage physician prescribed programs on their neurostimulation device from Abbott. The app also features educational resources on therapy topics that matter most to you, including video content about your neurostimulation device. This app works with rechargeable and non-rechargeable neurostimulation devices from Abbott such as the Eterna™ SCS system, Proclaim™ SCS and DRG systems, and the Liberta™ and Infinity™ DBS systems. The app utilizes Bluetooth wireless technology to communicate between the implanted stimulator, the stimulator charger (if you have a rechargeable stimulator) and is compatible with the mobile device patient controller provided by Abbott, as well as personal Apple mobile devices. * Key features of the app include: • Accessing educational resources that answer frequently asked questions about neurostimulation. • Sharing how you are feeling with your care team through digital check-in (this feature applies for chronic pain patients implanted with a neurostimulation device). • Connecting with Abbott’s Therapy Navigation Center for personalized device support (this feature applies for chronic pain patients implanted with a neurostimulation device). • Secure, in-app video chat sessions through NeuroSphere™ Virtual Clinic, enabling users to connect with their clinicians for routine remote programming adjustments. • Selecting stimulation programs for changing therapy needs. • Adjusting stimulation amplitude. • Checking device battery / monitoring charging status of the battery / adjusting charging settings (these features apply if you have a rechargeable stimulator). • Turning stimulation, MRI mode, and surgery mode ON / OFF. THIS APP DOES NOT PROVIDE MEDICAL ADVICE, NOR SHOULD BE REGARDED AS COMPRISING MEDICAL ADVICE OF ANY NATURE. THE APP IS NOT A SUBSTITUTE FOR THE PROFESSIONAL JUDGEMENT AND TREATMENT BY A PHYSICIAN OR MEDICAL PROFESSIONAL. PATIENTS SHOULD CONSULT WITH THEIR PHYSICIAN PRIOR TO MAKING ANY MEDICAL DECISIONS. IF YOU SUSPECT YOU MAY HAVE A MEDICAL EMERGENCY, PLEASE CONTACT EMERGENCY SERVICES OR YOUR HEALTHCARE PROVIDER. *Available on eligible mobile devices. For a list of mobile devices compatible with Abbott’s Neuromodulation Patient Controller applications, visit http://www.NMmobiledevicesync.com/cp Please note: • This application will work on Appleⱡ mobile devices running iOS 16.0 or later. • For the Privacy Policy see https://www.virtualclinic.abbott/policies • For the Terms of Use see https://www.virtualclinic.abbott/policies • Bluetooth is a registered trademark of Bluetooth SIG
NeuroSphere Digital Health App

Classifica degli store

La classifica del store si basa su diversi parametri stabiliti da Google e Apple.

Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci

NeuroSphere Digital Health AppStatistiche di ranking nel tempo

Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per NeuroSphere Digital Health App

Rank

Nessun dato disponibile

NeuroSphere Digital Health App Classifica per paese

Paesi in cui NeuroSphere Digital Health App ha la posizione più alta nelle sue categorie principali

Nessun dato da visualizzare

Principali concorrenti e app alternative

App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.

Patient Controller NR - US

Patient Controller NR - US

St. Jude Medical, Inc.

mySCS

mySCS

Boston Scientific

DoctorPlan

DoctorPlan

DOCTORBOX HEALTH, INC.

MyPainSolution

MyPainSolution

COMMONWEALTH PAIN ASSOCIATES, PLLC

NeuroSphere Digital Health App VS.

gennaio 14, 2026